Jun
2026
Pennsylvania Convention Center, Philadelphia
Visit us
stand 619

Nantong Jinghua Pharmaceutical co., Ltd.

Exhibitor at CPHI Americas 2026
About Us


Nantong Jinghua Pharmaceutical Co Ltd is a comprehensive, advanced and innovative GMP company, we focus on manufacture, R&D and sales of APIs, pharmaceutical intermediates. Our company produce Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil etc., in which the fist five products have CEP certificates.



Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +86 513 85609405
  • Website
  • No.20, 3 Haibin Road, Yanhai, Yanhai Economic Development Zone, Rudong, 226407, Nantong, Jiangsu, China
Show contact info Hide contact info
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 619

Products Featured at CPHI Americas 2026

  • Letermovir

    Product Letermovir

    use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients. It is the first of a new class of CMV anti-infectives called DNA terminase complex inhibitors. 
  • INDOCYANINE GREEN

    Product INDOCYANINE GREEN

    Indocyanine green is a Diagnostic Dye. The mechanism of action of indocyanine green is as a Dye.
  • Phenobarbital

    Product Phenobarbital

    There are CEP and US DMF for this product, our main markets are regulatory market, such South America and European.
  • Fluorouracil

    Product Fluorouracil

    There are CEP certificate and US DMF, approved by TGA, FDA and COFERPIS.
  • Phenylbutazone

    Product Phenylbutazone

    There are CEP certificate and US VMF, approved by FDA for more than three years. Our main markets are European and US.